首页|模式识别受体在糖尿病心肌病中的研究进展

模式识别受体在糖尿病心肌病中的研究进展

Pattern Recognition Receptors in Diabetic Cardiomyopathy

扫码查看
糖尿病心肌病(DCM)是糖尿病患者死亡的主要原因,但确切调控机制仍不清楚.近年研究发现,固有免疫应答是DCM发展过程的中心环节.模式识别受体是执行固有免疫功能的重要分子,主要包括Toll样受体、NOD样受体、视黄酸诱导基因Ⅰ样受体、C型凝集素受体、黑色素瘤缺乏因子2样受体、清道夫受体和环状GMP-AMP合成酶.现就上述几种模式识别受体在DCM中作用的研究进展进行综述,以期为DCM的临床治疗提供新思路和新靶点.
Diabetic cardiomyopathy(DCM)is a leading cause of death among patients with diabetes,yet the precise regulatory mechanisms remain unclear.Recent studies have discovered that the innate immune response plays a central role in the progression of DCM.Pattern recognition receptors are critical molecules that execute the functions of the innate immune system,including Toll-like receptor,NOD-like receptor,retinoic acid-inducible gene-Ⅰ-like receptor,C-type lectin receptor,absent in melanoma 2-like receptor,scavenger receptor,and cyclic GMP-AMP synthase.This review summarizes the research progress on the role of these pattern recognition receptors in DCM,aiming to provide new insights and targets for the clinical treatment of DCM.

Diabetic cardiomyopathyPattern recognition receptorInnate immune responseInflammation reaction

董泽耀、庄小密、鲁静

展开 >

哈尔滨医科大学附属第一医院,黑龙江哈尔滨 150001

糖尿病心肌病 模式识别受体 固有免疫应答 炎症反应

黑龙江省博士后科研启动资助金

LBH-Q20119

2024

心血管病学进展
成都市心血管病研究所,成都市第三人民医院

心血管病学进展

CSTPCD
影响因子:0.932
ISSN:1004-3934
年,卷(期):2024.45(6)
  • 1